These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

657 related articles for article (PubMed ID: 28418888)

  • 1. Significance of PI3K/AKT signaling pathway in metastasis of esophageal squamous cell carcinoma and its potential as a target for anti-metastasis therapy.
    Li B; Xu WW; Lam AKY; Wang Y; Hu HF; Guan XY; Qin YR; Saremi N; Tsao SW; He QY; Cheung ALM
    Oncotarget; 2017 Jun; 8(24):38755-38766. PubMed ID: 28418888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DEPTOR suppresses the progression of esophageal squamous cell carcinoma and predicts poor prognosis.
    Ji YM; Zhou XF; Zhang J; Zheng X; Li SB; Wei ZQ; Liu T; Cheng DL; Liu P; Song K; Tan T; Zhu H; Guo JL
    Oncotarget; 2016 Mar; 7(12):14188-98. PubMed ID: 26893358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Id-1 promotes tumorigenicity and metastasis of human esophageal cancer cells through activation of PI3K/AKT signaling pathway.
    Li B; Tsao SW; Li YY; Wang X; Ling MT; Wong YC; He QY; Cheung AL
    Int J Cancer; 2009 Dec; 125(11):2576-85. PubMed ID: 19551863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HPV16 E6-E7 induces cancer stem-like cells phenotypes in esophageal squamous cell carcinoma through the activation of PI3K/Akt signaling pathway in vitro and in vivo.
    Xi R; Pan S; Chen X; Hui B; Zhang L; Fu S; Li X; Zhang X; Gong T; Guo J; Zhang X; Che S
    Oncotarget; 2016 Aug; 7(35):57050-57065. PubMed ID: 27489353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MMP1 promotes tumor growth and metastasis in esophageal squamous cell carcinoma.
    Liu M; Hu Y; Zhang MF; Luo KJ; Xie XY; Wen J; Fu JH; Yang H
    Cancer Lett; 2016 Jul; 377(1):97-104. PubMed ID: 27130665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
    Lu C; Shan Z; Hong J; Yang L
    Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-146b promotes PI3K/AKT pathway hyperactivation and thyroid cancer progression by targeting PTEN.
    Ramírez-Moya J; Wert-Lamas L; Santisteban P
    Oncogene; 2018 Jun; 37(25):3369-3383. PubMed ID: 29353884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-214 promotes cell meastasis and inhibites apoptosis of esophageal squamous cell carcinoma via PI3K/AKT/mTOR signaling pathway.
    Guanen Q; Junjie S; Baolin W; Chaoyang W; Yajuan Y; Jing L; Junpeng L; Gaili N; Zhongping W; Jun W
    Biomed Pharmacother; 2018 Sep; 105():350-361. PubMed ID: 29864623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylation decreases the Bin1 tumor suppressor in ESCC and restoration by decitabine inhibits the epithelial mesenchymal transition.
    Wang X; Wang J; Jia Y; Wang Y; Han X; Duan Y; Lv W; Ma M; Liu L
    Oncotarget; 2017 Mar; 8(12):19661-19673. PubMed ID: 28152502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transforming growth factor-β1-induced epithelial-mesenchymal transition in human esophageal squamous cell carcinoma via the PTEN/PI3K signaling pathway.
    Zhang HY; Wang ZQ; Li YY; Wang F; Zeng QR; Gao Y; Xuan XY; Li SS
    Oncol Rep; 2014 Nov; 32(5):2134-42. PubMed ID: 25175594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osthole inhibits the PI3K/AKT signaling pathway via activation of PTEN and induces cell cycle arrest and apoptosis in esophageal squamous cell carcinoma.
    Zhu X; Li Z; Li T; Long F; Lv Y; Liu L; Liu X; Zhan Q
    Biomed Pharmacother; 2018 Jun; 102():502-509. PubMed ID: 29579711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Luteolin enhances drug chemosensitivity by downregulating the FAK/PI3K/AKT pathway in paclitaxel‑resistant esophageal squamous cell carcinoma.
    Yang Z; Liu H; Song Y; Gao N; Gao P; Hui Y; Li Y; Fan T
    Int J Mol Med; 2024 Sep; 54(3):. PubMed ID: 38994756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solute Carrier Family 39 Member 6 Gene Promotes Aggressiveness of Esophageal Carcinoma Cells by Increasing Intracellular Levels of Zinc, Activating Phosphatidylinositol 3-Kinase Signaling, and Up-regulating Genes That Regulate Metastasis.
    Cheng X; Wei L; Huang X; Zheng J; Shao M; Feng T; Li J; Han Y; Tan W; Tan W; Lin D; Wu C
    Gastroenterology; 2017 Jun; 152(8):1985-1997.e12. PubMed ID: 28209530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BMI-1 suppression increases the radiosensitivity of oesophageal carcinoma via the PI3K/Akt signaling pathway.
    Yang XX; Ma M; Sang MX; Zhang XY; Liu ZK; Song H; Zhu SC
    Oncol Rep; 2018 Feb; 39(2):667-678. PubMed ID: 29207170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RhoE functions as a tumor suppressor in esophageal squamous cell carcinoma and modulates the PTEN/PI3K/Akt signaling pathway.
    Zhao H; Yang J; Fan T; Li S; Ren X
    Tumour Biol; 2012 Oct; 33(5):1363-74. PubMed ID: 22477709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-126 is down-regulated in human esophageal squamous cell carcinoma and inhibits the proliferation and migration in EC109 cell via PI3K/AKT signaling pathway.
    Nie ZC; Weng WH; Shang YS; Long Y; Li J; Xu YT; Li Z
    Int J Clin Exp Pathol; 2015; 8(5):4745-54. PubMed ID: 26191164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ALC1 knockdown enhances cisplatin cytotoxicity of esophageal squamous cell carcinoma cells by inhibition of glycolysis through PI3K/Akt pathway.
    Li F; Zhang Z; Wang P; Wen P; Xu Q; Wang Y; Pan P; Ma L
    Life Sci; 2019 Sep; 232():116679. PubMed ID: 31340168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-130b plays an oncogenic role by repressing PTEN expression in esophageal squamous cell carcinoma cells.
    Yu T; Cao R; Li S; Fu M; Ren L; Chen W; Zhu H; Zhan Q; Shi R
    BMC Cancer; 2015 Jan; 15():29. PubMed ID: 25637514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DHRS2 inhibits cell growth and motility in esophageal squamous cell carcinoma.
    Zhou Y; Wang L; Ban X; Zeng T; Zhu Y; Li M; Guan XY; Li Y
    Oncogene; 2018 Feb; 37(8):1086-1094. PubMed ID: 29106393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor activity of celastrol by inhibition of proliferation, invasion, and migration in cholangiocarcinoma via PTEN/PI3K/Akt pathway.
    Zhu B; Wei Y
    Cancer Med; 2020 Jan; 9(2):783-796. PubMed ID: 31957323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.